TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Brief Summary: This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in participants with Stage III or IV ovarian cancer. Participants must have completed front-line platinum based regimen with complete response (CR) or partial response (PR). Data collection for Secondary Outcome measures is ongoing and the approximate duration of the study will be 7 years.


Options:
A: Arm Label: A: Paclitaxel; Type: ACTIVE_COMPARATOR; Interventions: Drug: Paclitaxel | Arm Label: B: Olaparib; Type: EXPERIMENTAL; Interventions: Drug: Olaparib | Arm Label: C: Olaparib and Cediranib; Type: EXPERIMENTAL; Interventions: Drug: Olaparib, Drug: Cediranib | Intervention Type: DRUG; Name: Olaparib; Assigned to Arm(s): B: Olaparib, C: Olaparib and Cediranib | Intervention Type: DRUG; Name: Cediranib; Assigned to Arm(s): C: Olaparib and Cediranib | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): A: Paclitaxel
B: Arm Label: avelumab; Type: EXPERIMENTAL; Interventions: Biological: avelumab | Arm Label: avelumab plus pegylated liposomal doxorubicin (PLD); Type: EXPERIMENTAL; Interventions: Biological: avelumab, Drug: PLD | Arm Label: PLD; Type: ACTIVE_COMPARATOR; Interventions: Drug: PLD | Intervention Type: BIOLOGICAL; Name: avelumab; Assigned to Arm(s): avelumab, avelumab plus pegylated liposomal doxorubicin (PLD) | Intervention Type: DRUG; Name: PLD; Assigned to Arm(s): PLD, avelumab plus pegylated liposomal doxorubicin (PLD)
C: Arm Label: Part 1 (Phase 1); Type: EXPERIMENTAL; Interventions: Drug: Rucaparib | Arm Label: Part 2A (Phase 2); Type: EXPERIMENTAL; Interventions: Drug: Rucaparib | Arm Label: Part 2B (Phase 2); Type: EXPERIMENTAL; Interventions: Drug: Rucaparib | Arm Label: Part 3 (Phase 2); Type: EXPERIMENTAL; Interventions: Drug: Rucaparib | Intervention Type: DRUG; Name: Rucaparib; Assigned to Arm(s): Part 1 (Phase 1), Part 2A (Phase 2), Part 2B (Phase 2), Part 3 (Phase 2)
D: Arm Label: Participants receiving Niraparib; Type: EXPERIMENTAL; Interventions: Drug: Niraparib | Arm Label: Participants receiving Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Niraparib; Assigned to Arm(s): Participants receiving Niraparib | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Participants receiving Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assessment and Treatment of Patients With Long-term Dizziness in Primary Care
Brief Summary: Brief Summary:

The purpose of the present study is to examine the effects of a Group based intervention consisting of vestibular rehabilitation (VR) combined with cognitive behavioral therapy (CBT) in patients with long--lasting vestibular dizziness. The study also aims to describe sociodemographic, physical and psychological characteristics in the patients, and to examine prognostic factors related to functional status and disability following participation in the intervention.

Prior to the RCT, a feasibility study will be conducted to examine the feasibility of the study protocol.


Options:
A: Arm Label: BI + VR + CBT; Type: EXPERIMENTAL; Interventions: Behavioral: BI + VR + CBT, Behavioral: BI + phone calls | Arm Label: BI + phone calls; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: BI + VR + CBT, Behavioral: BI + phone calls | Intervention Type: BEHAVIORAL; Name: BI + VR + CBT; Assigned to Arm(s): BI + VR + CBT, BI + phone calls | Intervention Type: BEHAVIORAL; Name: BI + phone calls; Assigned to Arm(s): BI + VR + CBT, BI + phone calls
B: Arm Label: Computer-training; Type: EXPERIMENTAL; Interventions: Procedure: Computer-training | Arm Label: Printed instructions; Type: EXPERIMENTAL; Interventions: Procedure: Computer-training | Intervention Type: PROCEDURE; Name: Computer-training; Assigned to Arm(s): Computer-training, Printed instructions
C: Arm Label: SVD-tailored Integrative Psychotherapy (IPT); Type: EXPERIMENTAL; Interventions: Behavioral: SVD-tailored Integrative Psychotherapy (IPT) | Arm Label: Self-help group (SHG); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-help group (SHG) | Intervention Type: BEHAVIORAL; Name: SVD-tailored Integrative Psychotherapy (IPT); Assigned to Arm(s): SVD-tailored Integrative Psychotherapy (IPT) | Intervention Type: BEHAVIORAL; Name: Self-help group (SHG); Assigned to Arm(s): Self-help group (SHG)
D: Arm Label: Gongjin-dan; Type: EXPERIMENTAL; Interventions: Drug: Gongjin-Dan | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Gongjin-Dan; Assigned to Arm(s): Gongjin-dan | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ultrasound-guided Fascia Iliaca Compartment Block Versus Periarticular Infiltration for Pain Management After Total Hip Arthroplasty: A Randomized Controlled Trial
Brief Summary: This randomized, controlled, observer-blinded study clinical trial was designed to evaluate ultrasound-guided fascia iliaca compartment block with ropivacaine and periarticular infiltration with ropivacaine for postoperative pain management after total hip arthroplasty.


Options:
A: Arm Label: Standard Treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Continuous fascia iliaca block; Type: EXPERIMENTAL; Interventions: Procedure: Continuous fascia iliaca block, Drug: Ropivacaine | Intervention Type: PROCEDURE; Name: Continuous fascia iliaca block; Assigned to Arm(s): Continuous fascia iliaca block | Intervention Type: DRUG; Name: Ropivacaine; Assigned to Arm(s): Continuous fascia iliaca block
B: Arm Label: regional anesthesia; Type: N/A; Interventions: N/A | Arm Label: systemic analgesia; Type: N/A; Interventions: N/A
C: Arm Label: Compartment Block; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ropivacaine, Drug: Epinephrine | Arm Label: Infiltration; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ropivacaine, Drug: Epinephrine | Intervention Type: DRUG; Name: Ropivacaine; Assigned to Arm(s): Compartment Block, Infiltration | Intervention Type: DRUG; Name: Epinephrine; Assigned to Arm(s): Compartment Block, Infiltration
D: Arm Label: General Anesthesia with nerve block; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Femoral Nerve Block | Arm Label: General Anesthesia no nerve block; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Femoral Nerve Block; Assigned to Arm(s): General Anesthesia with nerve block

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Resistance Training in Adults With Complex Congenital Heart Disease
Brief Summary: Adults with complex congenital heart disease have impaired muscle function compared both to health controls and patients with lesions classified as simple. There is only one study assessing the effects of resistance training in patients palliated with Fontan procedure. The hypotheses of the present study is that home based resistance training will improve muscle function in adults with different complex congenital hear diseases.


Options:
A: Arm Label: Fitbit Only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physical Activity Monitoring | Arm Label: Fitbit + Coaching Sessions; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Lifestyle Intervention, Behavioral: Physical Activity Monitoring | Intervention Type: BEHAVIORAL; Name: Physical Activity Lifestyle Intervention; Assigned to Arm(s): Fitbit + Coaching Sessions | Intervention Type: BEHAVIORAL; Name: Physical Activity Monitoring; Assigned to Arm(s): Fitbit + Coaching Sessions, Fitbit Only
B: Arm Label: Resistance training; Type: EXPERIMENTAL; Interventions: Behavioral: Home based resistance training | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home based resistance training; Assigned to Arm(s): Resistance training
C: Arm Label: Aerobic training only; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise training | Arm Label: Combined aerobic and strength training; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise training | Intervention Type: BEHAVIORAL; Name: Exercise training; Assigned to Arm(s): Aerobic training only, Combined aerobic and strength training
D: Arm Label: Aerobic Exercise Training Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Aerobic Exercise Training | Arm Label: Inspiratory Muscle Training Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Inspiratory Muscle Training | Arm Label: No Exercise Trainint Group; Type: ACTIVE_COMPARATOR; Interventions: Other: No Exercise Training | Intervention Type: OTHER; Name: Aerobic Exercise Training; Assigned to Arm(s): Aerobic Exercise Training Group | Intervention Type: OTHER; Name: Inspiratory Muscle Training; Assigned to Arm(s): Inspiratory Muscle Training Group | Intervention Type: OTHER; Name: No Exercise Training; Assigned to Arm(s): No Exercise Trainint Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Resistance Training in Adults With Complex Congenital Heart Disease
Brief Summary: Adults with complex congenital heart disease have impaired muscle function compared both to health controls and patients with lesions classified as simple. There is only one study assessing the effects of resistance training in patients palliated with Fontan procedure. The hypotheses of the present study is that home based resistance training will improve muscle function in adults with different complex congenital hear diseases.


Options:
A: Arm Label: Aerobic Exercise Training Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Aerobic Exercise Training | Arm Label: Inspiratory Muscle Training Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Inspiratory Muscle Training | Arm Label: No Exercise Trainint Group; Type: ACTIVE_COMPARATOR; Interventions: Other: No Exercise Training | Intervention Type: OTHER; Name: Aerobic Exercise Training; Assigned to Arm(s): Aerobic Exercise Training Group | Intervention Type: OTHER; Name: Inspiratory Muscle Training; Assigned to Arm(s): Inspiratory Muscle Training Group | Intervention Type: OTHER; Name: No Exercise Training; Assigned to Arm(s): No Exercise Trainint Group
B: Arm Label: Fitbit Only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physical Activity Monitoring | Arm Label: Fitbit + Coaching Sessions; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Lifestyle Intervention, Behavioral: Physical Activity Monitoring | Intervention Type: BEHAVIORAL; Name: Physical Activity Lifestyle Intervention; Assigned to Arm(s): Fitbit + Coaching Sessions | Intervention Type: BEHAVIORAL; Name: Physical Activity Monitoring; Assigned to Arm(s): Fitbit + Coaching Sessions, Fitbit Only
C: Arm Label: Resistance training; Type: EXPERIMENTAL; Interventions: Behavioral: Home based resistance training | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home based resistance training; Assigned to Arm(s): Resistance training
D: Arm Label: Cardiac Rehabilitation Peer Mentorship; Type: EXPERIMENTAL; Interventions: Behavioral: Cardiac Rehabilitation Peer Mentorship | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cardiac Rehabilitation Peer Mentorship; Assigned to Arm(s): Cardiac Rehabilitation Peer Mentorship

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: This study evaluates the early infant feeding in the infant intestinal microecology and the long term health. 300 healthy term newborns were involved into the study on its first stage. Depending on the type of feeding the infants were divided into 3 groups with random allocation to one of the formula feeding groups: the group A included 100 infants consuming the formula supplement with superior quality whey protein, the group B -100 infants fed with a standard formula, and the group C -100 infants who were breastfed.


Options:
A: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Other: Modified infant formula | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard infant formula | Arm Label: Breast-fed Reference Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Modified infant formula; Assigned to Arm(s): Experimental Group | Intervention Type: OTHER; Name: Standard infant formula; Assigned to Arm(s): Control Group
B: Arm Label: Breast Fed reference group; Type: N/A; Interventions: N/A | Arm Label: Infant formula - protein level 1; Type: N/A; Interventions: N/A | Arm Label: Infant formula - protein level 2; Type: N/A; Interventions: N/A
C: Arm Label: Infant Formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Infant Formula | Arm Label: Breast Milk; Type: OTHER; Interventions: Dietary Supplement: breast milk | Intervention Type: DIETARY_SUPPLEMENT; Name: Infant Formula; Assigned to Arm(s): Infant Formula | Intervention Type: DIETARY_SUPPLEMENT; Name: breast milk; Assigned to Arm(s): Breast Milk
D: Arm Label: Lower protein formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lower protein formula; Higher protein formula | Arm Label: Higher protein formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Lower protein formula; Higher protein formula | Arm Label: Breastfed reference group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Lower protein formula; Higher protein formula; Assigned to Arm(s): Higher protein formula, Lower protein formula

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does Local Endometrial Injury Improve Implantation Rates in Women Undergoing Their First ICSI Cycle.
Brief Summary: Midluteal single endometrial strip will be taken using a Novak curett under general anasthesia to avoid discomfort and cramping and to proceed to cervical dilatation in case of forbidden cervix, the step that will be beneficial to embryo transfer procedure.

Controller ovarian hyperstimulation; will be done using the long luteal phase agonist protocol and the short protocol(as judged by patient,s age ovarian reserve judged by day 3 FSH and antral follicular count and previous history of ovarian response).

Ovarian response will be monitored by vaginal ultrasound and HCG will be given when when there is \>=1 follicle \>=18 mm. and \>=3 follicles \>=16 mm. Ultasound guided oocyte retrieval will be carried out 35 hours later. Embryo transfer will be performed on day 2 or day 3 after oocyt retrieval according to number and quality of embryos.

Embryo transfer will be carried out under trans-abdominal ultrasound guidance pregnancy test will be done using qualitative blood HCG detection 2 weeks after the embryo transfer.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Endometrial biopsy | Intervention Type: OTHER; Name: Endometrial biopsy; Assigned to Arm(s): Intervention
B: Arm Label: GROUP A: intervention group; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial scratch | Arm Label: GROUP B: no intervention group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Endometrial scratch; Assigned to Arm(s): GROUP A: intervention group
C: Arm Label: endometrial scratch injury; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endometrial scratch injury | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Endometrial scratch injury; Assigned to Arm(s): endometrial scratch injury
D: Arm Label: group 1 : IVF with biopsy; Type: EXPERIMENTAL; Interventions: Procedure: biopsy | Arm Label: group 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: IVF | Intervention Type: PROCEDURE; Name: biopsy; Assigned to Arm(s): group 1 : IVF with biopsy | Intervention Type: PROCEDURE; Name: IVF; Assigned to Arm(s): group 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 5-day, Multicentre, Randomized, Open-label, Parallel Group, Active Control Pilot Study to Evaluate the Efficacy and Safety of OxyNorm® (Oxycodone Hydrochloride Injection) in Comparison With Morphine Sulfate Through the IV Continuous Infusion Regimen in Patients With Cancer Pain
Brief Summary: The purpose of this study is to compare of difference in NRS scores from baseline to the completion of treatment (5 days) in patients with administration of morphine sulfate versus oxycodone hydrochloride.


Options:
A: Intervention Type: DRUG; Name: oxycodone fentanyl; Assigned to Arm(s): N/A
B: Arm Label: 001; Type: EXPERIMENTAL; Interventions: Drug: R331333 (referred to as JNS024 ER or CG5503) | Arm Label: 002; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone CR | Intervention Type: DRUG; Name: Oxycodone CR; Assigned to Arm(s): 002 | Intervention Type: DRUG; Name: R331333 (referred to as JNS024 ER or CG5503); Assigned to Arm(s): 001
C: Arm Label: Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine | Arm Label: Oxycodone; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone | Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Fentanyl; Type: EXPERIMENTAL; Interventions: Drug: Fentanyl | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine | Intervention Type: DRUG; Name: Fentanyl; Assigned to Arm(s): Fentanyl | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine | Intervention Type: DRUG; Name: Oxycodone; Assigned to Arm(s): Oxycodone
D: Arm Label: Oxycodone Hydrochloride; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone Hydrochloride | Arm Label: Morphine Sulphate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine Sulphate | Intervention Type: DRUG; Name: Oxycodone Hydrochloride; Assigned to Arm(s): Oxycodone Hydrochloride | Intervention Type: DRUG; Name: Morphine Sulphate; Assigned to Arm(s): Morphine Sulphate

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impacts of Using Amr's Maneuver (Cervical Traction) on Atonic Postpartum Hemorrhage; Multi-centre Randomized Controlled Study
Brief Summary: The impacts of using Amr's manoeuvre (cervical traction) on atonic postpartum hemorrhage is a randomized controlled, multi-centre study that aims to compare the incidence of post partum hemorrhage (PPH\> 500 ml blood loss) within the first 24 hours of labor after using Amr's maneuver with active management of the third stage versus active management alone


Options:
A: Arm Label: Amr Maneuver; Type: EXPERIMENTAL; Interventions: Procedure: Amr maneuver | Arm Label: Active management alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Amr maneuver; Assigned to Arm(s): Amr Maneuver
B: Arm Label: Tampostat; Type: EXPERIMENTAL; Interventions: Device: Tampostat | Arm Label: Condom catheter tamponade; Type: ACTIVE_COMPARATOR; Interventions: Device: Condom catheter tamponade | Intervention Type: DEVICE; Name: Tampostat; Assigned to Arm(s): Tampostat | Intervention Type: DEVICE; Name: Condom catheter tamponade; Assigned to Arm(s): Condom catheter tamponade
C: Arm Label: stepwise uterine devascularization; Type: ACTIVE_COMPARATOR; Interventions: Procedure: stepwise uterine devascularization | Arm Label: A glove-loaded Foley's catheter; Type: EXPERIMENTAL; Interventions: Procedure: A glove-loaded Foley's catheter tamponade | Intervention Type: PROCEDURE; Name: A glove-loaded Foley's catheter tamponade; Assigned to Arm(s): A glove-loaded Foley's catheter | Intervention Type: PROCEDURE; Name: stepwise uterine devascularization; Assigned to Arm(s): stepwise uterine devascularization
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: OTHER; Interventions: Device: non-pneumatic anti-shock garment | Intervention Type: DEVICE; Name: non-pneumatic anti-shock garment; Assigned to Arm(s): Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Compared Efficacy of Nurse-led and GP-led Geriatric Assessment in PrImary Care: A Pragmatic Three-arm Cluster Randomized Controlled Trial
Brief Summary: Older patients account for around 10% of the population, of which 57% have a long-term illness, and 33% were admitted in the past year.

Geriatric assessment (GA) is a multidimensional assessment of general health status that can help identifying deficiencies and followed by a personalized care plan.

Assessment and management of elderly patients is a daily concern for the general practitioner (GP) but conflicting results have been reported so far relating to the clinical impact of GA when applied in the primary care setting.

This study protocol aims to assess the effect on morbi-mortality of a complex intervention in patients aged ≥70 years with chronic conditions in primary care. It aims to demonstrate that a GA adapted to primary care, followed by a personalized care plan and combined with successful interprofessional collaboration can improve clinically relevant outcomes in elderly patients with chronic conditions such as one-year overall mortality, unplanned hospital admission, emergency visits, or institutionalization.

The CEPIA study will also help addressing the issue of whether an improved benefit could be achieved from a systematic nurse-led or a case-by-case GP-led GA.


Options:
A: Arm Label: One-on-one counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lifestyle and medication intervention | Arm Label: Web counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lifestyle and medication intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle and medication intervention; Assigned to Arm(s): One-on-one counseling, Web counseling
B: Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Text or Portal; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: EHR + (Text or Portal) | Intervention Type: BEHAVIORAL; Name: EHR + (Text or Portal); Assigned to Arm(s): Text or Portal
C: Arm Label: SHHE Peridischarge intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SHHE Peridischarge Intervention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SHHE Peridischarge Intervention; Assigned to Arm(s): SHHE Peridischarge intervention
D: Arm Label: Systematic nurse-led GA; Type: EXPERIMENTAL; Interventions: Other: health care organization | Arm Label: GP-led GA on a case-by-case basis, as decided by the GP; Type: EXPERIMENTAL; Interventions: Other: health care organization | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: health care organization; Assigned to Arm(s): GP-led GA on a case-by-case basis, as decided by the GP, Systematic nurse-led GA

Answer: D